This method synchronize the heartbeat with the beginning of the TR, whereat the r wave is used as the trigger. Cardiac gating times the acquisition of MR data to physiological motion in order to minimize motion artifacts. ECG gating techniques are useful whenever data acquisition is too slow to occur during a short fraction of the cardiac cycle.
Image blurring due to cardiac-induced motion occurs for imaging times of above approximately 50 ms in systole, while for imaging during diastole the critical time is of the order of 200-300 ms. The acquisition of an entire image in this time is only possible with using ultrafast MR imaging techniques. If a series of images using cardiac gating or real-time echo planar imaging EPI are acquired over the entire cardiac cycle, pixel-wise velocity and vascular flow can be obtained.
In simple cardiac gating, a single image line is acquired in each cardiac cycle. Lines for multiple images can then be acquired successively in consecutive gate intervals. By using the standard multiple slice imaging and a spin echo pulse sequence, a number of slices at different anatomical levels is obtained. The repetition time (TR) during a ECG-gated acquisition equals the RR interval, and the RR interval defines the minimum possible repetition time (TR). If longer TRs are required, multiple integers of the RR interval can be selected. When using a gradient echo pulse sequence, multiple phases of a single anatomical level or multiple slices at different anatomical levels can be acquired over the cardiac cycle.
Also called cardiac triggering.

Quick Overview

Movement of the heart causes blurring and ghosting in the images. The artifacts appear in the phase encoding direction, independent of the direction of the motion.

These artifacts can be reduced by using cardiac synchronization: triggering, gating or retrospective triggering. Maximum reduction can be achieved by using triggering in combination with flow compensation, respiratory triggering or breath hold and regional saturation techniques.

See also Motion Artifact.

Short name: Code 7228, generic name: Ferumoxytol, central moiety: Fe
Code 7228 is the code name for a substance in the development pipeline (AMAG Pharmaceuticals, Inc.) for use as a contrast agent in magnetic resonance angiography (MRA). Ferumoxytol, as a true blood pool agent, resides in the vascular space for an extended period of time and does not leak out into adjacent tissues like currently used gadolinium-based contrast agents. The product is being evaluated in MRA applications for the detection of blood flow in the heart muscle, in exploratory studies for the diagnosis of vulnerable plaque and as a next generation lymph node agent.
Code 7228 is currently in approval phase for use as an iron replacement therapeutic in chronic kidney disease patients receiving erythropoetin.
It is presently contemplated that Ferumoxytol will compete with the contrast agents Vasovist™ from EPIX Pharmaceuticals, Inc. and NC100150 Injection from Nycomed Amersham.

(CRISP) A specific pulse sequence, wherein the application of strategic gradient pulses can compensate for the objectionable spin phase effects of flow motion.

(CAD) 'Computer aided detection' or 'computer assisted diagnosis' systems are tools to improve the efficiency and workflow in medical imaging procedures. The aim of CAD is to increase the diagnostic accuracy of screening procedures by using a computer system to locate abnormalities, improve image management, correct patient movement and assist the radiologists in the interpretation and analysis of data-intensive studies. Typical applications include the tumor detection in mammography, breast MRI, colonography, and lung imaging. Newer applications like prostate MRI are under investigation.

See also MR Guided Interventions, Breast MRI and Hybrid Imaging.